Translating Human Genetics into Novel Treatment Targets for Schizophrenia
Human genetics is a rational starting point for target identification in drug discovery, yet this approach has found little application in neuroscience. Recent large-scale analyses have begun to identify robust genetic loci for schizophrenia, providing an opportunity to derive novel drug targets. He...
Gespeichert in:
Veröffentlicht in: | Neuron (Cambridge, Mass.) Mass.), 2014-11, Vol.84 (3), p.537-541 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Human genetics is a rational starting point for target identification in drug discovery, yet this approach has found little application in neuroscience. Recent large-scale analyses have begun to identify robust genetic loci for schizophrenia, providing an opportunity to derive novel drug targets. Here, we summarize a strategy for applying human genetics to neuroscience drug discovery.
Human genetics is a rational starting point for target identification in drug discovery, yet this approach has found little application in neuroscience. Recent large-scale analyses have begun to identify robust genetic loci for schizophrenia, providing an opportunity to derive novel drug targets. Here, Schubert et al. summarize a strategy for applying human genetics to neuroscience drug discovery. |
---|---|
ISSN: | 0896-6273 1097-4199 |
DOI: | 10.1016/j.neuron.2014.10.037 |